192 related articles for article (PubMed ID: 17620384)
1. Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model.
Tan CH; Li J; Nation RL
Antimicrob Agents Chemother; 2007 Sep; 51(9):3413-5. PubMed ID: 17620384
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.
Córdoba J; Coronado-Álvarez NM; Parra D; Parra-Ruiz J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7316-9. PubMed ID: 26369956
[TBL] [Abstract][Full Text] [Related]
3. fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.
Dudhani RV; Turnidge JD; Nation RL; Li J
J Antimicrob Chemother; 2010 Sep; 65(9):1984-90. PubMed ID: 20573659
[TBL] [Abstract][Full Text] [Related]
4. Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/pharmacodynamic model.
Lee HJ; Bergen PJ; Bulitta JB; Tsuji B; Forrest A; Nation RL; Li J
Antimicrob Agents Chemother; 2013 Aug; 57(8):3738-45. PubMed ID: 23716052
[TBL] [Abstract][Full Text] [Related]
5. Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance.
Cheah SE; Li J; Tsuji BT; Forrest A; Bulitta JB; Nation RL
Antimicrob Agents Chemother; 2016 Jul; 60(7):3921-33. PubMed ID: 27067324
[TBL] [Abstract][Full Text] [Related]
6. Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
Kroeger LA; Hovde LB; Mitropoulos IF; Schafer J; Rotschafer JC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3431-3. PubMed ID: 17576842
[TBL] [Abstract][Full Text] [Related]
7. Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii.
Bian X; Liu X; Feng M; Bergen PJ; Li J; Chen Y; Zheng H; Song S; Zhang J
Int J Antimicrob Agents; 2021 Feb; 57(2):106271. PubMed ID: 33352235
[TBL] [Abstract][Full Text] [Related]
8. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
[TBL] [Abstract][Full Text] [Related]
9. Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model.
Liu X; Zhao M; Chen Y; Bian X; Li Y; Shi J; Zhang J
Int J Antimicrob Agents; 2016 Nov; 48(5):559-563. PubMed ID: 27670371
[TBL] [Abstract][Full Text] [Related]
10. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an
Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
Cai X; Yang Z; Dai J; Chen K; Zhang L; Ni W; Wei C; Cui J
Int J Antimicrob Agents; 2017 May; 49(5):609-616. PubMed ID: 28315729
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of an in vitro pharmacokinetic/pharmacodynamic model to test the antibacterial efficacy of antibiotic polymer conjugates.
Azzopardi EA; Ferguson EL; Thomas DW
Antimicrob Agents Chemother; 2015 Apr; 59(4):1837-43. PubMed ID: 25512401
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii.
Phee LM; Kloprogge F; Morris R; Barrett J; Wareham DW; Standing JF
J Antimicrob Chemother; 2019 Apr; 74(4):961-969. PubMed ID: 30624656
[TBL] [Abstract][Full Text] [Related]
14. Novel rate-area-shape modeling approach to quantify bacterial killing and regrowth for in vitro static time-kill studies.
Cheah SE; Li J; Nation RL; Bulitta JB
Antimicrob Agents Chemother; 2015 Jan; 59(1):381-8. PubMed ID: 25367905
[TBL] [Abstract][Full Text] [Related]
15. Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model.
Bergen PJ; Tsuji BT; Bulitta JB; Forrest A; Jacob J; Sidjabat HE; Paterson DL; Nation RL; Li J
Antimicrob Agents Chemother; 2011 Dec; 55(12):5685-95. PubMed ID: 21911563
[TBL] [Abstract][Full Text] [Related]
16. In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii.
Plachouras D; Giamarellos-Bourboulis EJ; Kentepozidis N; Baziaka F; Karagianni V; Giamarellou H
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):419-22. PubMed ID: 17188449
[TBL] [Abstract][Full Text] [Related]
17. Atomic force microscopy investigation of the morphology and topography of colistin-heteroresistant Acinetobacter baumannii strains as a function of growth phase and in response to colistin treatment.
Soon RL; Nation RL; Hartley PG; Larson I; Li J
Antimicrob Agents Chemother; 2009 Dec; 53(12):4979-86. PubMed ID: 19786595
[TBL] [Abstract][Full Text] [Related]
18. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.
Yau W; Owen RJ; Poudyal A; Bell JM; Turnidge JD; Yu HH; Nation RL; Li J
J Infect; 2009 Feb; 58(2):138-44. PubMed ID: 19058855
[TBL] [Abstract][Full Text] [Related]
19. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.
Li J; Rayner CR; Nation RL; Owen RJ; Spelman D; Tan KE; Liolios L
Antimicrob Agents Chemother; 2006 Sep; 50(9):2946-50. PubMed ID: 16940086
[TBL] [Abstract][Full Text] [Related]
20. Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol.
Wei WJ; Yang HF
Int J Antimicrob Agents; 2017 Mar; 49(3):321-326. PubMed ID: 28167347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
